Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19584250rdf:typepubmed:Citationlld:pubmed
pubmed-article:19584250lifeskim:mentionsumls-concept:C0001026lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C0028013lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C1428910lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C0205681lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:19584250lifeskim:mentionsumls-concept:C0870071lld:lifeskim
pubmed-article:19584250pubmed:issue29lld:pubmed
pubmed-article:19584250pubmed:dateCreated2009-7-22lld:pubmed
pubmed-article:19584250pubmed:abstractTextA dinuclear nickel complex with methyl and thiolate ligands, Ni(dadt(Et))Ni(Me)(SDmp) (2), has been synthesized as a dinuclear Ni(d)-Ni(p)-site model of acetyl-CoA synthase (ACS) (dadt(Et) is N,N'-diethyl-3,7-diazanonane-1,9-dithiolate; Dmp is 2,6-dimesitylphenyl). Complex 2 was prepared via 2 methods: (i) ligand substitution of a dinuclear Ni(II)-Ni(II) cation complex [Ni(dadt(Et)) Ni(tmtu)2] (OTf)2 (1) with MeMgBr and KSDmp (tmtu is tetramethylthiourea), (ii) methyl transfer from methylcobaloxime Co(dmgBF2)2(Me)(Py) (5) to a Ni(II)-Ni(0) complex such as [Ni(dadt(Et))Ni(cod)] (3), generated in situ from Ni(dadt(Et)) and Ni(cod)(2), followed by addition of KSDmp (cod is 1,5-cyclooctadiene; dmgBF2 is difluoroboryl-dimethylglyoximate). Method ii models the formation of Nip-Me species proposed as a plausible intermediate in ACS catalysis. The reaction of 2 with excess CO affords the acetylthioester CH3C(O)SDmp (8) with concomitant formation of Ni(dadt(Et))Ni(CO)2 (9) and Ni(CO)4 plus Ni(dadt(Et)). When complex 2 is treated with 1 equiv of CO in the presence of excess 1,5-cyclooctadiene, the formation of 9 and Ni(CO)4 is considerably suppressed, and instead the dinuclear Ni(II)-Ni(0) complex is generated in situ, which further affords 2 upon successive treatment with Co(dmgBF2)2(Me)(Py) (5) and KSDmp. These results suggest that (i) ACS catalysis could include the Nid(II)-Nip(0) state as the active species, (ii) The Nid(II)-Nip(0) species could first react with methylcobalamin to afford Nid(II)-Nip(II)-Me, and (iii) CO insertion into the Nip-Me bond and the successive reductive elimination of acetyl-CoA occurs immediately when CoA is coordinated to the Nip site to form the active Nid(II)-Nip(0) species.lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:languageenglld:pubmed
pubmed-article:19584250pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:citationSubsetIMlld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19584250pubmed:statusMEDLINElld:pubmed
pubmed-article:19584250pubmed:monthJullld:pubmed
pubmed-article:19584250pubmed:issn1091-6490lld:pubmed
pubmed-article:19584250pubmed:authorpubmed-author:TatsumiKazuyu...lld:pubmed
pubmed-article:19584250pubmed:authorpubmed-author:MatsumotoTsuy...lld:pubmed
pubmed-article:19584250pubmed:authorpubmed-author:ItoMikinaoMlld:pubmed
pubmed-article:19584250pubmed:authorpubmed-author:KoteraMaiMlld:pubmed
pubmed-article:19584250pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19584250pubmed:day21lld:pubmed
pubmed-article:19584250pubmed:volume106lld:pubmed
pubmed-article:19584250pubmed:ownerNLMlld:pubmed
pubmed-article:19584250pubmed:authorsCompleteYlld:pubmed
pubmed-article:19584250pubmed:pagination11862-6lld:pubmed
pubmed-article:19584250pubmed:dateRevised2010-9-27lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:meshHeadingpubmed-meshheading:19584250...lld:pubmed
pubmed-article:19584250pubmed:year2009lld:pubmed
pubmed-article:19584250pubmed:articleTitleDinuclear nickel complexes modeling the structure and function of the acetyl CoA synthase active site.lld:pubmed
pubmed-article:19584250pubmed:affiliationDepartment of Chemistry, Graduate School of Science, and Research Center for Materials Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8602, Japan.lld:pubmed
pubmed-article:19584250pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19584250pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19584250lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19584250lld:pubmed